Journal of the American Chemical Society
Article
enantioenriched, amino-tethered alkenes to form an in situ
generated imido osmium intermediate and promote an
intramolecular 1,2-oxyamination.10 In 2008, Chemler and co-
workers disclosed an enantioselective, intramolecular 1,2-
oxyamination of alkenes, combining unsaturated sulfonamides
with copper(II) catalysts, chiral bisoxazoline (BOX) ligands,
and TEMPO (Scheme 1b).11 This method displays good to
excellent yields and enantioselectivities in which the
regioselectivity is controlled by intramolecularity. Follow-up
studies demonstrate that either enantiomer can be accessed by
this method through a judicious choice of the chiral BOX
ligand.
use as potential redox-active catalysts is of considerable interest
(Scheme 2). Upon initial opening of the -iranium ion with a
nucleophile, a secondary nucleophile can displace the catalyst,
allowing for the 1,2-difunctionalization and regeneration of the
catalyst. However, an oxidative step is necessary to turn over
the redox process. Halogen(I/III)-based catalysts are released
in a lower oxidation state than is required for -iranium
formation and must be reoxidized to promote the -iranium
formation. Iodine has been employed as a catalyst in this
process to generate racemic oxazolines18 and enantioenriched
oxazolidinones19 using chiral iodine reagents. In contrast, some
chalcogen(II) catalysts must be oxidized to form a chalcogen-
(IV) leaving group for the second nucleophile addition.
Alternatively, some Se(II) species can serve as a competent
nucleofuge but then must be oxidized to the Se(IV) species to
reenter the catalytic cycle. By comparison to the use of iodine
as a redox catalyst to effect 1,2-oxyamination of alkenes, the
use of chalcogens for this purpose remains underexplored.
Scheme 1. Foundational Examples of Enantioselective 1,2-
Oxyamination of Alkenes
Scheme 2. General Flow for a Redox-Active Halogen/
Chalcogen Catalysis
Although chalcogens have seen prior use in the dual opening
of -iranium ions to effect 1,2-oxyamination of alkenes, this has
historically been conducted using stoichiometric amounts of
the chalcogen-based reagent. This strategy was first demon-
strated in 1988 by Ogura and co-workers using benzenetellur-
inyl trifluoroacetate to form the telluriranium ion, with opening
by the nitrile solvent in a Ritter-type process that ultimately
displaces the tellurium through an invertive process that
reduces the tellurium reagent (Scheme 3a).20 Shortly there-
after, Tiecco and co-workers demonstrated that stoichiometric
amounts of diphenyl diselenide, in the presence of an oxidant,
can react with alkenes to form a seleniranium ion that can be
opened by a variety of nucleophiles to provide 1,2-amino
alcohol scaffolds upon displacement of the selenium (Scheme
3b).21 This reaction platform generates 1,2-azido ethers,
oxazolines, and oxazolidinones. Although this reaction was
initially conducted as a two-step process with the alkyl selenide
as an intermediate, subsequent studies by these authors found
that the use of phenylselenenyl sulfate as the selenium source
allows for a one-pot protocol for the formation of oxazolines.22
The authors propose that the formation of a cationic diselenide
from the alkyl selenide intermediate promotes the second
nucleophilic attack and loss of the selenide.
Shortly thereafter, Yoon and co-workers discovered a pair of
complementary methods for the enantioselective formation of
oxazolidines from oxaziridines (Scheme 1c).12 In this strategy,
terminal olefins are functionalized enantioselectively using
chiral BOX ligands to provide access to either constitutional
isomer, depending on the choice of copper or iron as the
catalyst. Good yields and enantioselectivities are observed in
both cases, with excellent cis/trans diastereomeric selectivity in
the iron catalysis system. Additional enantioselective alkene
1,2-oxyamination methods have been developed using (1)
stoichiometric amounts of manganese,13 (2) catalytic processes
that employ copper,14 palladium,15 and iridium complexes,16
and (3) bioenzymatic catalysis.17
Another promising strategy that has been employed for
stereoselective 1,2-oxyamination of alkenes is the use of a
redox-active catalyst that can form a highly electrophilic
-iranium ion when combined with an alkene substrate.
Chalcogens and halogens in rows 3−5 are often used for
vicinal alkene difunctionalizations via -iranium ions, and their
A recent report from our laboratories demonstrated that a
chiral diselenide can be used catalytically to effect enantiose-
lective formation of oxazolidinones from alkenes and a
carbamate in the presence of a mild oxidant to promote
catalytic turnover (Scheme 3c).23,24 Drawing on knowledge
13409
J. Am. Chem. Soc. 2021, 143, 13408−13417